Quick Answer
Benitec Biopharma Inc. reported Operating Income of -$41.77 million for fiscal year 2025.
Benitec Biopharma Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$41.77M | -85.7% |
| 2024 | -$22.49M | -17.9% |
| 2023 | -$19.08M | -6.9% |
| 2022 | -$17.85M | -31.3% |
| 2021 | -$13.60M | -64.2% |
| 2020 | -$8.28M | -420.6% |
| 2019 | $2.58M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$13.38M | -23.8% | -36.5% |
| September 30, 2025 | -$9.80M | -69.3% | +3.8% |
| March 31, 2025 | -$10.19M | -146.0% | +5.7% |
| December 31, 2024 | -$10.80M | -56.0% | -86.6% |
| September 30, 2024 | -$5.79M | +1.4% | -39.8% |
| March 31, 2024 | -$4.14M | +4.6% | +40.2% |
| December 31, 2023 | -$6.93M | -23.5% | -17.9% |
| September 30, 2023 | -$5.87M | -28.3% | -35.3% |
- Benitec Biopharma Inc. showed a decrease of -85.7% in Operating Income compared to the prior fiscal year.
- Over the 2019–2025 period, Benitec Biopharma Inc.’s operating income has declined by 1716.9% (from $2.58 million to -$41.77 million).
- The most recent figure is from Benitec Biopharma Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 22, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: